Hospital Universitario de La Plana
Villarreal, Castellón, 12540, Spain
NCT Number: NCT03624335
This study compares two umbilical cord clamping times; the early one, up to a minute (ECC) and the late or delayed one, when the cord stop beating (DCC). The additional blood volume delivered to the newborn from the placenta - placental transference - by delaying umbilical cord ligation, increases the contribution of neonatal iron with increased iron stores in the infant, without increasing neonatal morbidity.
Looking for future studies?
Notify Me35 week–42 week
All sexes
Interventional
Not applicable
Villarreal, Castellón, 12540, Spain
It is an intervention study without drugs administration with a longitudinal, prospective comparison and correlational design.
Patients are recruited by simple random sampling to one of the two intervention groups:
Group 1-ECC: Early clamping of the umbilical cord (before the first minute of life).
Group 2-DCC: Delayed clamping of the umbilical cord (when it stops beating).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Early clamping of the umbilical cord
Delayed clamping of the umbilical cord
Blood Test 6hours
Blood Test 24hours
Blood Test 48hours
Blood Test 28days
Time frame: 6hours
haemoglobin level
Time frame: 28 days
haemoglobin level
Time frame: 6 hours
haematocrit level
Time frame: 28 days
haematocrit level
Time frame: 6hours
serum ferritin level
Time frame: 28days
serum ferritin level
Time frame: 6hours
bilirubin level
Time frame: 28days
bilirubin level
Pascual Gregori Roig
Other
Influence of Umbilical Cord Clamping Time in the Newborn, Secondary Neonatal Morbidity and Iron Deposits in the Neonate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07502781
Anemia, Anemia Neonatal
Barcelona, Spain
View Trial DetailsNCT06921330
ABO Incompatibility, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Karabük, Karabük Province, Turkey (Türkiye)
View Trial DetailsNCT03741803
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Houston, Texas, United States
View Trial DetailsNCT06209489
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Karabük, Turkey (Türkiye)
View Trial Details